No categories for this tab

About Us

About PharmaCountry
How It Works
Partnerships
Sustainability
Contact Us

For Buyers

Search Products
Search Services
Find Suppliers
Find Jobs
Find Seekers
Help Center
FAQ
Buyer Protection

For Sellers/Service Providers

Start Selling
Seller Guide
Pricing Plans
Advertising
Seller Support

Top Categories

Active Pharmaceutical Ingredients (APIs)
Finished Dosage Forms
Manufacturing Equipment & Utilities
Excipients & Additives
View All Categories

Stay Connected

[email protected]

24/7 Customer Support

Trusted B2B Platform

SSL Secure Transactions Verified Suppliers Quality Assured B2B Certified Global Network

© 2026 PharmaCountry. All rights reserved.

Privacy Policy Terms of Service Cookie Policy

MELIANE 0,075 mg / 0,02 mg COMPRIMIDOS RECUBIERTOS | Pharmacountry

Products
Finished Dosage Forms
Tablets
Immediate-Release Tablets

MELIANE 0,075 mg / 0,02 mg COMPRIMIDOS RECUBIERTOS

BA

Bayer

Marketing Authorization Holder · Finished Dosage FormsUnited States

Ratings

(0)

(0)

(0)

(0)

(0)

Leave your rating & comment

Comments

Filters:

Sort by:

No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product

Basic Information

Category

Finished Dosage Forms

Subcategory & Sub-subcategory

Tablets / Immediate-Release Tablets

Trade Type

Sell

Product Name

MELIANE 0,075 mg / 0,02 mg COMPRIMIDOS RECUBIERTOS

Details

ETINILESTRADIOL 0,02 mg • GESTODENO 0,075 mg

Substance

ETINILESTRADIOL • GESTODENO

Registered Market

Spain

Distributor(s)

Ecofar Productos S.L. - Spain.

Specifications

Dosage Form: Tablet
ATC Code: G03AA10
Packaging: MELIANE 0,075 mg / 0,02 mg tablets coated, 21 tablets • MELIANE 0,075 mg / 0,02 mg tablets coated, 63 (3 x 21) tablets

Documents

Drug Marketing Authorization Number

Document No.: BE174124IP3

Issue Date: Jan 12, 2022